Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Trading here in the US yesterday was "compelling" - IMHO ;-)
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(800)
•••
Post by SouthernTierTomon May 04, 2021 12:21pm
390 Views
Post# 33123880

Trading here in the US yesterday was "compelling" - IMHO ;-)

Trading here in the US yesterday was "compelling" - IMHO ;-)
(TLTFF)
Naked Short Interest
TLTFF
- Short Volume Report  (REGSHO)
All RegSho Dated reported by: FINRA
Regular VolumeShort VolumeApr 05Apr 07Apr 09Apr 13Apr 15Apr 19Apr 21Apr 26Apr 28Apr 30Apr 06Apr 08Apr 12Apr 14Apr 16Apr 20Apr 23Apr 27Apr 29May 030500,0001,000,0001,500,0002,000,000Highcharts.com
Historical Short Volume Data for TLTFF
Date Close High Low Volume Short Volume % of Vol Shorted
May 03 NA NA NA 1,631,829 459,496 28.16
Apr 30 NA NA NA 61,535 10,035 16.31
Apr 29 NA NA NA 45,740 17,678 38.65
Apr 28 NA NA NA 187,740 90,540 48.23
Apr 27 NA NA NA 178,768 155,260 86.85
Apr 26 NA NA NA 63,375 18,100 28.56
Apr 23 NA NA NA 282,581 277,175 98.09
Apr 21 NA NA NA 15,776 13,776 87.32
Apr 20 NA NA NA 60,015 25,817 43.02
Apr 19 NA NA NA 34,151 31,239 91.47
Apr 16 NA NA NA 29,417 15,541 52.83
Apr 15 NA NA NA 48,847 24,647 50.46
Apr 14 NA NA NA 43,450 20,580 47.36
Apr 13 NA NA NA 58,430 58,430 100.00
Apr 12 NA NA NA 106,707 87,007 81.54
Apr 09 NA NA NA 242,267 181,665 74.99
Apr 08 NA NA NA 39,900 5,350 13.41
Apr 07 NA NA NA 60,499 44,920 74.25
Apr 06 NA NA NA 39,073 34,203 87.54
Apr 05 NA NA NA 21,491 5,500 25.59

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities